Strides Pharma
STAR.NSSTAR.NS · Stock Price
Historical price data
Overview
Strides Pharma Science Limited is a multinational pharmaceutical company with a mission to make quality healthcare accessible globally through a hybrid business model spanning regulated and emerging markets. Founded in 1990, it has evolved from a domestic Indian manufacturer into a global leader in complex generics and specialty pharmaceuticals, leveraging a vertically integrated structure with advanced manufacturing and R&D. Key achievements include a 5x increase in Q4 FY2025 net profit, a strategic 'In Africa, For Africa' initiative, and a robust portfolio of USFDA-approved facilities, positioning it for sustainable growth in the global generics market.
Technology Platform
Integrated platform for complex generics and biosimilars, specializing in advanced formulation technologies for softgels, sterile injectables, controlled substances, and leveraging vertical integration from API to finished dosage forms.
Pipeline
1| Drug | Indication | Stage | Watch |
|---|---|---|---|
| Favipiravir + Nitazoxanide | Covid19 | Phase 2 |
Funding History
2FDA Approved Drugs
50Competitors
Company Timeline
Founded in Bengaluru, India
Initial Public Offering
Debt: $50.0M
FDA Approval: FLUOXETINE HYDROCHLORIDE
FDA Approval: THEOPHYLLINE
FDA Approval: SUCRALFATE